PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Asia Pacific Technical Regulatory Policy, Pharma Technical Regulatory Policy and International Operations, Roche Singapore Technical Operations, F. Hoffmann La-Roche Ltd, Singapore, Singapore. sannie.chong@roche.com.\', \'National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Republic of Korea.\', \'U.S. Food and Drug Administration, Washington, DC, USA.\', \'APEC Life Sciences Innovation Forum, Washington, DC, USA.\', \'Biotechnology Innovation Organization, Washington, DC, USA.\', \'Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.\', \'Duke-NUS Medical School, Centre of Regulatory Excellence, Singapore, Singapore.\', \'SingHealth Duke-NUS Global Health Institute, Singapore, Singapore.\', \'Consortium for Clinical Research & Innovation Singapore, Singapore, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s43441-021-00285-w
?:hasPublicationType
?:journal
  • Therapeutic innovation & regulatory science
is ?:pmid of
?:pmid
?:pmid
  • 33840083
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Measuring Progress of Regulatory Convergence and Cooperation Among Asia-Pacific Economic Cooperation (APEC) Member Economies in the Context of the COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33840083>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33840083>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all